Bumrungrad Hospital Public Company Limited

$5.45+0.00%(+$0.00)
TickerSpark Score
68/100
Solid
63
Valuation
100
Profitability
20
Growth
96
Health
60
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BUHPF research report →

52-Week Range75% of range
Low $4.85
Current $5.45
High $5.65

Companywww.bumrungrad.com

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center. Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers.

CEO
Artirat Charukitpipat
IPO
2010
Employees
4,506
HQ
Bangkok, TH

Price Chart

+12.37% · this period
$5.65$5.25$4.85May 20Nov 18May 20

Valuation

Market Cap
$4.33B
P/E
18.22
P/S
5.46
P/B
4.26
EV/EBITDA
13.07
Div Yield
6.34%

Profitability

Gross Margin
51.97%
Op Margin
34.93%
Net Margin
29.96%
ROE
25.10%
ROIC
20.90%

Growth & Income

Revenue
$25.11B · -2.35%
Net Income
$7.51B · -3.46%
EPS
$9.46 · -3.27%
Op Income
$8.77B
FCF YoY
-10.31%

Performance & Tape

52W High
$5.65
52W Low
$4.85
50D MA
$5.55
200D MA
$5.24
Beta
0.24
Avg Volume
1

Get TickerSpark's AI analysis on BUHPF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our BUHPF Coverage

We haven't published any research on BUHPF yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate BUHPF Report →

Similar Companies